The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. aTyr Pharma's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. aTyr Pharma's average Accounts Receivable for the
three
months ended in Dec. 2023 was $0.00 Mil.
aTyr Pharma Receivables Turnover Historical Data
The historical data trend for aTyr Pharma's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of aTyr Pharma's Receivables Turnover
For the Biotechnology subindustry, aTyr Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aTyr Pharma's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, aTyr Pharma's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where aTyr Pharma's Receivables Turnover falls into.
aTyr Pharma Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
aTyr Pharma's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
aTyr Pharma Receivables Turnover Related Terms
Thank you for viewing the detailed overview of aTyr Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LIFE has been successfully added to your 